title: Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.
abstract: OBJECTIVE
  A previous positron emission tomography (PET) study reported increased serotonin 5-HT(2A) receptor binding in unmedicated depressed patients with high scores on the Dysfunctional Attitudes Scale. The purpose of the present study was to use the highly selective 5-HT(2A) receptor ligand [(11)C]MDL 100,907 in a PET imaging paradigm to assess 1) 5-HT(2A) receptor binding potential in euthymic subjects with a history of recurrent depression and 2) the relationship between receptor binding and scores on the Dysfunctional Attitudes Scale.
  
  
  METHODS
  Cortical 5-HT(2A) receptor binding was measured in 20 unmedicated, fully recovered unipolar depressed patients and 20 age- and gender-matched comparison subjects. Regional estimates of binding potential were obtained using a reversible plasma input function compartmental model and the cerebellum as a reference region to estimate the free and non-specifically bound [(11)C]MDL 100,907 in brain tissue.
  
  
  RESULTS
  Relative to the comparison subjects, the recovered depressed patients demonstrated significantly higher 5-HT(2A) receptor binding potential in the frontal cortex (mean increase: 19%), parietal cortex (mean increase: 25%), and occipital cortex (mean increase: 19%). 5-HT(2A) receptor binding potential correlated negatively with age in both patients and comparison subjects and positively with the Dysfunctional Attitudes Scale in the recovered patients.
  
  
  CONCLUSIONS
  These findings should be considered preliminary but suggest that recovered subjects with a history of recurrent major depression have elevated binding potential of cortical 5-HT(2A) receptors. The correlation of increased 5-HT(2A) receptor binding potential with increased scores on Dysfunctional Attitudes Scale supports earlier work suggesting that increased 5-HT(2A) receptor availability characterizes a group of depressed patients with high levels of dysfunctional attitudes.
authors.affiliation: Clinical Neuroscience Research Unit, Abraham Ribicoff Research Facilities, 34 Park St., New Haven, CT 06519-1187, USA. zubin.bhagwagar@yale.edu
authors.forename: Zubin
authors.initials: Z
authors.lastname: Bhagwagar
authors.forename: Rainer
authors.initials: R
authors.lastname: Hinz
authors.forename: Matthew
authors.initials: M
authors.lastname: Taylor
authors.forename: Sabrina
authors.initials: S
authors.lastname: Fancy
authors.forename: Philip
authors.initials: P
authors.lastname: Cowen
authors.forename: Paul
authors.initials: P
authors.lastname: Grasby
mesh_terms: D000328:Adult; D001290:Attitude; D002250:Carbon Radioisotopes; D002531:Cerebellum / Q000000981:diagnostic imaging / Q000378:metabolism; D002540:Cerebral Cortex / Q000000981:diagnostic imaging / Q000378:metabolism*; D003866:Depressive Disorder / Q000175:diagnosis / Q000378:metabolism* / Q000523:psychology*; D005260:Female; D005464:Fluorobenzenes / Q000378:metabolism; D006801:Humans; D008297:Male; D010555:Personality Inventory / Q000706:statistics & numerical data; D010880:Piperidines / Q000378:metabolism; D049268:Positron-Emission Tomography / Q000706:statistics & numerical data*; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D044402:Receptor, Serotonin, 5-HT2A / Q000378:metabolism*; D012008:Recurrence; D014018:Tissue Distribution
chemical_list: D002250:Carbon Radioisotopes; D005464:Fluorobenzenes; D010880:Piperidines; D044402:Receptor, Serotonin, 5-HT2A; C079049:volinanserin